Multi-centre Clinical Trial on Hormone Replacement Treatment in China

NCT01698164 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

1200

Enrollment

OTHER

Sponsor class

Conditions

Menopausal Syndrome
Cardiovascular Disease
Osteoporosis
Breast Cancer

Interventions

DRUG: estradiol plus MPA
DRUG: Ximingting Tablet
DRUG: estradiol plus progesterone

Sponsor

Peking Union Medical College Hospital